{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:34:27Z","timestamp":1790886867505,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T00:00:00Z","timestamp":1271116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s10875-010-9401-x","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T08:27:43Z","timestamp":1271060863000},"page":"97-102","source":"Crossref","is-referenced-by-count":33,"title":["Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems"],"prefix":"10.1007","volume":"30","author":[{"given":"Angela","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,13]]},"reference":[{"key":"9401_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2006.09.024","volume":"52","author":"A Vincent","year":"2006","unstructured":"Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron. 2006;52:123\u201338.","journal-title":"Neuron"},{"key":"9401_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","volume":"28","author":"J Newsom-Davis","year":"1978","unstructured":"Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology. 1978;28:266\u201372.","journal-title":"Neurology"},{"key":"9401_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","volume":"190","author":"KV Toyka","year":"1975","unstructured":"Toyka KV, Brachman DB, Pestronk A, Kao I. Myasthenia gravis: passive transfer from man to mouse. Science. 1975;190:397\u20139.","journal-title":"Science"},{"key":"9401_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","volume":"296","author":"KV Toyka","year":"1977","unstructured":"Toyka KV, Drachman DB, Griffin DE, Pestronk A, Winkelstein JA, Fishbeck KH, et al. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med. 1977;296:125\u201331.","journal-title":"N Engl J Med."},{"key":"9401_CR5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2:797\u2013804.","journal-title":"Nat Rev Immunol."},{"key":"9401_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","volume":"1132","author":"N Willcox","year":"2008","unstructured":"Willcox N, Leite MI, Kadota Y, Jones M, Meager A, Subrahmanyam P, et al. Autoimmunizing mechanisms in thymoma and thymus. Ann NY Acad Sci. 2008;1132:163\u201373.","journal-title":"Ann NY Acad Sci."},{"key":"9401_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7:365\u20138.","journal-title":"Nat Med."},{"key":"9401_CR8","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain. 2008;131:1940\u201352.","journal-title":"Brain"},{"key":"9401_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","volume":"346","author":"A Vincent","year":"1995","unstructured":"Vincent A, Newland C, Brueton L, Beeson D, Riemersma S, Huson SM, et al. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet. 1995;346:24\u20135.","journal-title":"Lancet"},{"key":"9401_CR10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1096-9926(200011)62:5<332::AID-TERA7>3.0.CO;2-E","volume":"62","author":"A Polizzi","year":"2000","unstructured":"Polizzi A, Huson SM, Vincent A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology. 2000;62:332\u201341.","journal-title":"Teratology"},{"key":"9401_CR11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI5943","volume":"103","author":"L Jacobson","year":"1999","unstructured":"Jacobson L, Polizzi A, Morriss-Kay G, Vincent A. Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. J Clin Invest. 1999;103:1031\u20138.","journal-title":"J Clin Invest."},{"key":"9401_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ana.10557","volume":"53","author":"P Dalton","year":"2003","unstructured":"Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol. 2003;53:533\u20137.","journal-title":"Ann Neurol."},{"key":"9401_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1196\/annals.1254.019","volume":"998","author":"B Lang","year":"2003","unstructured":"Lang B, Pinto A, Giovannini F, Newsom-Davis J, Vincent A. Pathogenic autoantibodies in the Lambert\u2013Eaton myasthenic syndrome. Ann NY Acad Sci. 2003;998:187\u201395.","journal-title":"Ann NY Acad Sci."},{"key":"9401_CR14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","volume":"47","author":"PG Bain","year":"1996","unstructured":"Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome. Neurology. 1996;47:678\u201383.","journal-title":"Neurology"},{"key":"9401_CR15","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","volume":"125","author":"IK Hart","year":"2002","unstructured":"Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125:1887\u201395.","journal-title":"Brain"},{"key":"9401_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0140-6736(91)90073-X","volume":"338","author":"S Sinha","year":"1991","unstructured":"Sinha S, Newsom-Davis J, Mills K, Byrne N, Lang B, Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet. 1991;338:75\u20137.","journal-title":"Lancet"},{"key":"9401_CR17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","volume":"38","author":"P Shillito","year":"1995","unstructured":"Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995;38:714\u201322.","journal-title":"Ann Neurol."},{"key":"9401_CR18","doi-asserted-by":"crossref","unstructured":"Arimura K, Sonoda Y, Watanabe O, Nagado T, Kurono A, Tomimitsu H, et al. Isaacs' syndrome as a potassium channelopathy of the nerve. Muscle Nerve. 2002;(Suppl 11):55-58.","DOI":"10.1002\/mus.10148"},{"key":"9401_CR19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<672::AID-MUS21>3.0.CO;2-W","volume":"21","author":"P Maddison","year":"1998","unstructured":"Maddison P, Lawn N, Mills KR, Vincent A, Donaghy M. Acquired neuromyotonia in a patient with spinal epidural abscess. Muscle Nerve. 1998;21:672\u20134.","journal-title":"Muscle Nerve."},{"key":"9401_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jnnp.2005.075283","volume":"77","author":"MR Turner","year":"2006","unstructured":"Turner MR, Madkhana A, Ebers GC, Clover L, Vincent A, McGavin G, et al. Wasp sting induced autoimmune neuromyotonia. J Neurol Neurosurg Psychiatry. 2006;77:704\u20135.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"9401_CR21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","volume":"41","author":"IK Hart","year":"1997","unstructured":"Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol. 1997;41:238\u201346.","journal-title":"Ann Neurol."},{"key":"9401_CR22","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","volume":"124","author":"R Liguori","year":"2001","unstructured":"Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124:2417\u201326.","journal-title":"Brain"},{"key":"9401_CR23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.wnl.0000336972.62597.41","volume":"71","author":"M Spinazzi","year":"2008","unstructured":"Spinazzi M, Argentiero V, Zuliani L, Palmieri A, Tavolato B, Vincent A. Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome. Neurology. 2008;71:2008\u201310.","journal-title":"Neurology"},{"key":"9401_CR24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","volume":"21","author":"KA Josephs","year":"2004","unstructured":"Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol. 2004;21:440\u20135.","journal-title":"J Clin Neurophysiol."},{"key":"9401_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","volume":"50","author":"C Buckley","year":"2001","unstructured":"Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73\u20138.","journal-title":"Ann Neurol."},{"key":"9401_CR26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701\u201312.","journal-title":"Brain"},{"key":"9401_CR27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","volume":"62","author":"MJ Thieben","year":"2004","unstructured":"Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62:1177\u201382.","journal-title":"Neurology"},{"key":"9401_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.06.003","volume":"71","author":"HJ Majoie","year":"2006","unstructured":"Majoie HJ, de Baets M, Renier W, Lang B, Vincent A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 2006;71:135\u201341.","journal-title":"Epilepsy Res."},{"key":"9401_CR29","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","volume":"65","author":"K McKnight","year":"2005","unstructured":"McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology. 2005;65:1730\u20136.","journal-title":"Neurology"},{"key":"9401_CR30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","volume":"71","author":"SR Irani","year":"2008","unstructured":"Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology. 2008;71:1647\u20138.","journal-title":"Neurology"},{"key":"9401_CR31","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106\u201312.","journal-title":"Lancet"},{"key":"9401_CR32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473\u20137.","journal-title":"J Exp Med."},{"key":"9401_CR33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","volume":"65","author":"P Waters","year":"2008","unstructured":"Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008;65:913\u20139.","journal-title":"Arch Neurol."},{"key":"9401_CR34","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"S Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008;131:3072\u201380.","journal-title":"Brain"},{"key":"9401_CR35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008;4:202\u201314.","journal-title":"Nat Clin Pract Neurol."},{"key":"9401_CR36","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007;69:2221\u201331.","journal-title":"Neurology"},{"key":"9401_CR37","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","volume":"205","author":"SR Hinson","year":"2008","unstructured":"Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008;205:2473\u201381.","journal-title":"J Exp Med."},{"issue":"5","key":"9401_CR38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009;66(5):630\u201343.","journal-title":"Ann Neurol."},{"issue":"5","key":"9401_CR39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617\u201329.","journal-title":"Ann Neurol."},{"issue":"4","key":"9401_CR40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","volume":"386","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun. 2009;386(4):623\u20137.","journal-title":"Biochem Biophys Res Commun."},{"key":"9401_CR41","doi-asserted-by":"crossref","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of patient immunoglobulin and human complement produce neuromyelitis optica lesions in mice. Brain. 2010;133:349\u201361.","DOI":"10.1093\/brain\/awp309"},{"key":"9401_CR42","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","volume":"71","author":"M Hutchinson","year":"2008","unstructured":"Hutchinson M, Waters P, McHugh J, Gorman G, O'Riordan S, Connolly S, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;71:1291\u20132.","journal-title":"Neurology"},{"key":"9401_CR43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336.","journal-title":"Ann Neurol."},{"key":"9401_CR44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.","journal-title":"Lancet Neurol."},{"issue":"1","key":"9401_CR45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","volume":"66","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11\u20138.","journal-title":"Ann Neurol."},{"issue":"5","key":"9401_CR46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.21807","volume":"66","author":"RC Dale","year":"2009","unstructured":"Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, et al. N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66(5):704\u20139.","journal-title":"Ann Neurol."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-010-9401-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-010-9401-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:10:08Z","timestamp":1559275808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-010-9401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,13]]},"references-count":46,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["9401"],"URL":"https:\/\/doi.org\/10.1007\/s10875-010-9401-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,13]]}}}